Cargando…

Risk factors for adverse cardiac events in adults with fulminant myocarditis during hospitalization

BACKGROUND: Fulminant myocarditis is the critical form of myocarditis that is often associated with heart failure, malignant arrhythmia, and circulatory failure. Patients with fulminant myocarditis who end up with severe multiple organic failure and death are not rare. AIM: To analyze the predictors...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Tie-Duo, Ren, Yan-Long, Zhao, Han, Ning, Shang-Qiu, Liu, Wen-Xian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2020
Materias:	Case Control Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000935/ https://www.ncbi.nlm.nih.gov/pubmed/32047773 http://dx.doi.org/10.12998/wjcc.v8.i2.255

Ejemplares similares

Impact of mechanical circulatory support and immunomodulation therapy on outcome of patients with fulminant myocarditis: Chinese registry of fulminant myocarditis
por: Zhou, Ning, et al.
Publicado: (2021)

New concepts in fulminant myocarditis and risk of cardiac mortality
por: Ammirati, Enrico, et al.
Publicado: (2017)

Early characteristics of fulminant myocarditis vs non-fulminant myocarditis: A meta-analysis
por: Wang, Zicheng, et al.
Publicado: (2019)

Fulminant myocarditis in the time of coronavirus
por: Cuomo, Vittoria, et al.
Publicado: (2020)

Fulminant myocarditis and COVID-19
por: Joob, Beuy, et al.
Publicado: (2020)

COVID-Induced Fulminant Myocarditis
por: Rodriguez Guerra, Miguel A, et al.
Publicado: (2022)

Characteristics of Electrocardiogram Findings in Fulminant Myocarditis
por: Dai, Mei-Yan, et al.
Publicado: (2023)

Predictive Value of Electromechanical Activation Time for In-Hospital Major Cardiac Adverse Events in Heart Failure Patients
por: Zhang, Jing, et al.
Publicado: (2020)

Fulminant versus non fulminant acute myocarditis: evolution of functional parameters evaluated with cardiac magnetic resonance
por: Pedrotti, Patrizia, et al.
Publicado: (2016)

Fulminant myocarditis in adults: a narrative review
por: Montero, Santiago, et al.
Publicado: (2022)

Fulminant Bacterial Myocarditis Presenting as Myocardial Infarction
por: Trpkov, Cvetan, et al.
Publicado: (2020)

Extracorporeal Cardiopulmonary Resuscitation for Management of Out-of-Hospital Cardiac Arrest in a Patient with Fulminant Myocarditis
por: Meyer, Alexander J., et al.
Publicado: (2020)

Transient Myocarditis Associated with Fulminant Colitis
por: Williamson, J. M. L., et al.
Publicado: (2011)

Fulminant Guillain-Barré Syndrome with Myocarditis
por: Mishra, Ajay, et al.
Publicado: (2014)

Fulminant myocarditis: Characteristics, treatment, and outcomes
por: Veronese, Giacomo, et al.
Publicado: (2018)

Consideration on pathogen of viral fulminant myocarditis
por: Wei, Xin, et al.
Publicado: (2020)

Fulminant myocarditis and COVID-19. Response
por: Irabien-Ortiz, Ángela, et al.
Publicado: (2020)

Fulminant myocarditis due to COVID-19
por: Irabien-Ortiz, Ángela, et al.
Publicado: (2020)

Fulminant Eosinophilic Myocarditis and VT Storm
por: Hoppens, Kyle R., et al.
Publicado: (2021)

Tozinameran: Fulminant myocarditis: case report
Publicado: (2022)

Anakinra in pediatric acute fulminant myocarditis
por: Maunier, Louise, et al.
Publicado: (2022)

Successful use of equine anti-thymocyte globulin (ATGAM) for fulminant myocarditis secondary to nivolumab therapy
por: Tay, Rebecca Y, et al.
Publicado: (2017)

Cardiac Sarcoidosis or Giant Cell Myocarditis? On Treatment Improvement of Fulminant Myocarditis as Demonstrated by Cardiovascular Magnetic Resonance Imaging
por: Bogabathina, Hari, et al.
Publicado: (2012)

Bidirectional Ventricular Tachycardia in a Patient With Fulminant Myocarditis Secondary to Cardiac Sarcoidosis Mimicking Giant Cell Myocarditis
por: Durocher, Daniel, et al.
Publicado: (2021)

Clinical Characteristics and Adverse Events in Acute Coronary Syndrome Patients with a History of Peripheral Arterial Disease
por: Kang, Yun-Peng, et al.
Publicado: (2019)

ECMO as an effective rescue therapeutic for fulminant myocarditis complicated with refractory cardiac arrest
por: Li, Ya-Ting, et al.
Publicado: (2017)

Fulminant cardiac sarcoidosis resembling giant cell myocarditis: a case report
por: Jiang, Ginger Y, et al.
Publicado: (2021)

Associations with the In-Hospital Survival Following Extracorporeal Membrane Oxygenation in Adult Acute Fulminant Myocarditis
por: Chong, Shaur-Zheng, et al.
Publicado: (2018)

Mode-of-action of the PROPELLA concept in fulminant myocarditis
por: Spillmann, Frank, et al.
Publicado: (2019)

Parvovirus B19 Myocarditis of Fulminant Evolution
por: Spartalis, Michael, et al.
Publicado: (2017)

Fulminant myocarditis with myositis of ocular and respiratory muscles
por: Hiraiwa, Hiroaki, et al.
Publicado: (2020)

Glucocorticoid and immunoglobulin to treat viral fulminant myocarditis
por: Wei, Xin, et al.
Publicado: (2020)

SARS-CoV-2 Fulminant Myocarditis
por: Garot, Jérôme, et al.
Publicado: (2020)

Immune-mediated mechanism in coronavirus fulminant myocarditis
por: Wei, Xin, et al.
Publicado: (2020)

Azd-1222: Fulminant myocarditis: case report
Publicado: (2022)

Clinical and electrocardiographic characteristics in patients with fulminant myocarditis
por: Itoh, Tomonori, et al.
Publicado: (2022)

The absolute and relative changes in high-sensitivity cardiac troponin I are associated with the in-hospital mortality of patients with fulminant myocarditis
por: Liu, Chao, et al.
Publicado: (2021)

Phenotypic Heterogeneity of Fulminant COVID-19--Related Myocarditis in Adults
por: Barhoum, Petra, et al.
Publicado: (2022)

Case Report: COVID-19 Vaccination Associated Fulminant Myocarditis
por: Cui, Guanglin, et al.
Publicado: (2022)

COVID-19 FULMINANT MYOCARDITIS PROGRESSING TO CARDIAC TAMPONADE IN LESS THAN 24 HOURS
por: Ammar, Ali, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2025lgl09b32qt3i11l7oso08o